https://www.hayes-lab.com/research daily 0.75 2026-08-12 https://www.hayes-lab.com/research/from-satiety-to-substance-use-neural-mechanisms-of-glp-1-signaling-in-appetite-and-reward monthly 0.5 2026-08-12 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/99fd91b4-a028-4312-bb07-a2e408fa5343/Screenshot+2026-08-12+at+6.23.15%E2%80%AFPM.png Research - From Satiety to Substance Use: Neural Mechanisms of GLP-1 Signaling in Appetite and Reward - Make it stand out Table 2. Summary of the suppressive effects of GLP-1R agonists on drug taking/seeking behaviors from preclinical and clinical studies with different substance use disorders. CPP = conditioned place preference https://www.hayes-lab.com/research/the-locus-coeruleus-calcitonin-receptor-can-be-engaged-by-amylin-and-calcitonin-gene-related-peptide-to-suppress-feeding-without-inducing-nausea monthly 0.5 2026-08-12 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/4ad3d87a-5b76-432e-b334-d1360f03db13/gr6.jpg Research - The locus coeruleus calcitonin receptor can be engaged by amylin and calcitonin gene-related peptide to suppress feeding without inducing nausea - Make it stand out Feeding suppression by LC CTR neuron activation and calcitonin-family peptides and is not associated with nausea-related behavior. (A) Conditioned flavor preference in mouse. Preference ratio measured following pairing of flavored solutions with deschloroclozapine (DCZ) in control Dq-expressing mice (Ctrl Dq, n = 6) and calcitonin receptor–expressing LC Dq-expressing mice (CTR Dq, n = 6), or lithium chloride (LiCl) in control mice (n = 6). A one-way between-subjects ANOVA revealed a significant effect of treatment, with post hoc comparisons indicating reduced preference following LiCl but not following DCZ for either genotype. (B) In rat, cumulative kaolin intake measured over 1, 3, 6, and 24 h following administration of vehicle or salmon calcitonin (sCT; 0.04 μg/100 nl). No differences in kaolin intake were observed between vehicle- and sCT-treated conditions at any timepoint. (C) In rat, cumulative kaolin intake measured following vehicle or amylin (0.4 μg/100 nl). Amylin did not alter kaolin intake relative to vehicle at any timepoint examined. (D) In rat, cumulative kaolin intake measured following vehicle or CGRP (250 pmol/100 nl). CGRP did not alter kaolin intake relative to vehicle at any timepoint. For B-D, within-subject comparisons between vehicle and peptide conditions were performed using paired t tests at each timepoint ( n = 9). All data are presented as mean ± SEM with individual subjects shown. Groups not sharing a common letter differ significantly ( p < 0.05). https://www.hayes-lab.com/research/hypophagia-and-body-weight-loss-by-tirzepatide-are-accompanied-by-fewer-gi-adverse-events-compared-to-semaglutide-in-preclinical-models monthly 0.5 2026-06-11 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1f4214db-5f70-4f42-83a5-fae5ea262b01/sciadv.adu1589-f3.jpg Research - Hypophagia and body weight loss by tirzepatide are accompanied by fewer GI adverse events compared to semaglutide in preclinical models - Make it stand out (A) Semaglutide administration dose-dependently suppresses food intake in rats (10 and 100 nmol/kg, ip; n = 10 per group). (B) The highest tested dose of semaglutide causes significant malaise (i.e., kaolin intake) in rats (100 nmol/kg, ip; n = 10 per group). (C) Semaglutide administration causes body weight loss in a dose-dependent manner (10 and 100 nmol/kg, ip; n = 10 per group). (D) Tirzepatide (TZP) dose-dependently suppress food intake (10 and 100 nmol/kg, ip; n = 10 per group). (E) Systemic administration of tirzepatide (100 nmol/kg) causes significant kaolin intake (ip, n = 10 per group). (F) Tirzepatide dose-dependently suppresses body weight (10 and 100 nmol/kg, ip; n = 10). (G) Tirzepatide and semaglutide induce comparable hypophagic responses in rats compared to controls (100 nmol/kg, ip; n = 10 to 20 per group). (H) Semaglutide administration induces higher kaolin consumption than tirzepatide treatment (100 nmol/kg, ip; n = 10 to 20 per group). (I) Tirzepatide and semaglutide cause similar body weight loss (100 nmol/kg, ip; n = 10 to 20 per group). All data expressed as means ± SEM. Data in (A) to (F) were analyzed with repeated measures two-way ANOVA followed by Tukey’s post hoc tests. Data in (G) to (I) were analyzed with repeated measures mixed-effects model followed by Tukey’s post hoc tests. Means with different letters are significantly different from each other (P < 0.05). https://www.hayes-lab.com/research/the-estrous-cycle-moderates-the-food-and-body-weight-suppressive-effects-of-glucagon-like-peptide-1-receptor-agonism monthly 0.5 2026-06-11 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/9be944a5-5ce6-45eb-8bcb-ce2876b9410b/dom70177-fig-0001-m.jpg Research - The estrous cycle moderates the food and body weight suppressive effects of glucagon-like peptide-1 receptor agonism - Make it stand out In lean female rats, Glp1r expression was greater during combined Proestrus/Estrus (P/E) compared to animals in Metestrus/Diestrus (M/D) in the (A) Nucleus Accumbens, p = 0.0055, (B) Bed Nucleus of the Stria Terminalis, p = 0.0023, (D) Paraventricular Thalamic Nucleus, p = 0.0003, (E) Central Amygdala, p = 0.0016, (F) Arcuate Nucleus, p = 0.0002, and (G) Ventral Tegmental Area, p = 0.045, but not in the (C) Paraventricular Hypothalamic Nucleus, p = 0.378. n = 17–20/group, between-subjects design. p < 0.05; *p < 0.01; ***p < 0.001. https://www.hayes-lab.com/research/gipr-signaling-modulates-pyy-induced-hypophagia-and-malaise-in-rodents monthly 0.5 2026-06-11 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/ed180727-4072-4d46-9989-991cc2f10946/1-s2.0-S2212877826000189-gr2_lrg.jpg Research - GIPR signaling modulates PYY-induced hypophagia and malaise in rodents - Make it stand out Effects of systemic delivered LA-PYY (3, 10, 30, 100 and 300 nmol/kg, IP, n = 9/group) or vehicle on cumulative food intake (A), daily food intake (B) and kaolin intake (B) and body weight (C). Acute treatment with the GIPR agonist GIP-532 (10 nmol/kg, IP) in combination with LA-PYY (100 nmol/kg, IP) does not modify the food intake-suppressive effects (D) or body weight change (F) as seen with LA-PYY treatment alone. However, pre-treatment does attenuate the LA-PYY-induced kaolin intake, with a significant decrease at 24 h and 48 h (E). n = 12–14/group, data are expressed as means ± SEM. Means with different letters are significantly different from each other (P < 0.05) by two-way repeated measures ANOVA with Tukey's multiple comparison tests. https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/135e4098-3590-46b9-9f78-a2c4f09d6f1e/1-s2.0-S2212877826000189-gr3_lrg.jpg Research - GIPR signaling modulates PYY-induced hypophagia and malaise in rodents - Make it stand out A single injection of GIPR antibody GIPG013 (30 mg/kg, IP) does not affect food intake (A), kaolin intake (B), or body weight (C) (n = 12/group). Pre-treatment of the GIPR antibody GIPG013 (30 mg/kg) increases the anorexia from acute LA-PYY (100 nmol/kg) treatment alone, decreasing food intake (C)and reducing body weight (F). However, pre-treatment does not impact the kaolin intake as seen from acute treatment of LA-PYY alone (E) (n = 7–8/group). Data are expressed as means ± SEM. Data in (A and B), analyzed with two-way repeated measures ANOVA, followed by Sidak's multiple comparison tests, data in (D, E, and F) analyzed with two-way repeated measures ANOVA, followed by Tukey's multiple comparison tests, data in (C) tested with an unpaired t test. Means with different letters are significantly different from each other (P < 0.05). https://www.hayes-lab.com/research/corrination-of-a-glp-1-receptor-agonist-for-glycemic-control-without-emesis-7cdm6-thtrl-h85j6-xwfnn-gcps4 monthly 0.5 2026-05-07 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/a47bb927-ca87-4634-974e-b09c6d621e7d/dom70427-fig-0004-m.jpg Research - GLP-1R biased cAMP agonism maintains glycemic control with reduced malaise and emesis in preclinical mammalian models - Make it stand out Central TDN in rats and peripheral TDN in mice improves weight and glycemic control. https://www.hayes-lab.com/research/corrination-of-a-glp-1-receptor-agonist-for-glycemic-control-without-emesis-7cdm6-thtrl-h85j6-xwfnn monthly 0.5 2026-05-07 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/115502de-52bf-4a73-8821-a9365ae1b383/Screenshot+2025-09-17+at+11.55.34%E2%80%AFAM.png Research - Hindbrain octadecaneuropeptide gliotransmission as a therapeutic target for energy balance control without nausea or emesis - Make it stand out Central TDN in rats and peripheral TDN in mice improves weight and glycemic control. https://www.hayes-lab.com/research/corrination-of-a-glp-1-receptor-agonist-for-glycemic-control-without-emesis-7cdm6-thtrl-h85j6 monthly 0.5 2025-09-17 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/53ce343b-fb58-4a44-b6c0-6ea2ab3680ca/LC2.png Research - The locus coeruleus contributes to the anorectic, nausea, and autonomic physiological effects of glucagon-like peptide-1 - Make it stand out LC GLP-1R activation contributes to food intake control via enhanced glutamate signaling. (A) RNAscope analysis did not reveal Glp1r mRNA expression in LC NE neuron (DBH) soma. (B) LC NE neurons express N-methyl-d-aspartate (NMDA) receptors (Grin1A). (C) LC NE neurons express AMPA receptors (GluA1). (D) Pretreatment with an NMDA/AMPA antagonist cocktail [GluR antag; MK-801, 0.05 μg/CNQX (6-cyano-7-nitroquinoxaline-2,3-dione), 0.3 μg] attenuated the food intake-suppressive effects of LC Ex-4 (0.05 μg) at 3 and 6 hours after administration (n = 20). (E) MK-801/CNQX attenuated the food intake suppressive effects of LC Ex-4 at 24 hours (n = 20). (F) Twenty-four-hour body weight reduction by LC Ex-4 was not significantly affected by MK-801/CNQX pretreatment (n = 20). https://www.hayes-lab.com/research/corrination-of-a-glp-1-receptor-agonist-for-glycemic-control-without-emesis-3ghmy-n6gf2-rjd5w monthly 0.5 2024-08-06 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/f2ec7394-df2d-4329-a275-9b0eff92cde3/VTA+amylin+GABA.png Research - Amylin Modulates a Ventral Tegmental Area-to-Medial Prefrontal Cortex Circuit to Suppress Food Intake and Impulsive Food-Directed Behavior - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.hayes-lab.com/research/corrination-of-a-glp-1-receptor-agonist-for-glycemic-control-without-emesis-7cdm6-thtrl monthly 0.5 2024-08-06 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/0dbce653-1c56-4a96-976d-b33179827319/GIP+.png Research - GIP receptor agonism blocks chemotherapy-induced nausea and vomiting - Make it stand out GIPR agonism attenuates nausea and emesis in 3 different mammalian species. A) GIPR agonism (GIP-532, 3 nmol/kg, SC) blocks retching induced by the chemotherapeutic agent cisplatin (10 mg/kg, IP) in ferrets (n = 5/group). B) While cisplatin (10 mg/kg, IP) produces severe emesis in 4 out of 5 ferrets, pre-treatment with GIPR agonist GIP-523 (3 nmol/kg, SC) completely prevents cisplatin-induced vomiting (n = 5/group). C) GIPR agonism blocks the insurgence of cisplatin-induced emetic episodes (i.e. retching and vomiting) in ferrets (n = 5/group). D) Latency to the first emetic episode following each treatment condition in ferrets. E) In shrews, the profound emesis induced by cisplatin (30 mg/kg, IP) is significantly attenuated by GIP-085 (300 nmol/kg) pre-treatment (n = 8–16/group). F) Cumulative emetic episodes across time in shrews (n = 8–16/group). G) Latency to the first emetic episode following cisplatin treatment with or without GIPR agonist pre-treatment in shrews (n = 6–8/group). https://www.hayes-lab.com/research/corrination-of-a-glp-1-receptor-agonist-for-glycemic-control-without-emesis-3ghmy-n6gf2 monthly 0.5 2024-08-06 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/4884e80e-02da-4eb4-a513-7873f8b598bf/GPR160+fig+5.1.png Research - GPR-160 Receptor Signaling in the Dorsal Vagal Complex of Male Rats Modulates Meal Microstructure and CART-Mediated Hypophagia - Make it stand out DVC Gpr160 KD attenuates 4th icv CART mediated anorexigenic, but not locomotor or core body temperature effects. (A,B) Rats (AAV1-GFP control n = 8; AAV- Gpr160 KD n = 10) were administered 4th icv CART at the onset of the dark cycle and food intake and BW was assessed at the following timepoints 1-, 3-, 6-, 12- and 24-h. https://www.hayes-lab.com/research/corrination-of-a-glp-1-receptor-agonist-for-glycemic-control-without-emesis-7cdm6 monthly 0.5 2024-08-06 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/18eddd8c-3e2a-4edb-9123-6990851eb853/VTA+satH.png Research - Metabolic hormone action in the VTA: Reward-directed behavior and mechanistic insights - Make it stand out Satiation hormone signaling mechanisms in the VTA. The distinct mechanisms outlined for each hormone are indicated in the figure, legend, and manuscript text by the first letter of that hormone and the sequential number. A question mark is placed near any mechanisms which are hypothesized. https://www.hayes-lab.com/research/corrination-of-a-glp-1-receptor-agonist-for-glycemic-control-without-emesis-3ghmy monthly 0.5 2024-08-06 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/582742ba-26a7-456f-ad15-a7ab1da1a0d8/tzp+fig+for+website.png Research - Tirzepatide suppresses palatable food intake by selectively reducing preference for fat in rodents - Make it stand out Glucagon-like peptide-1 (GLP-1) receptor knockout eliminates dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonism-induced preference shift between 5-day choice chow and 60% high-fat diet (HFD). https://www.hayes-lab.com/research/corrination-of-a-glp-1-receptor-agonist-for-glycemic-control-without-emesis monthly 0.5 2024-08-06 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1634060173007-417OZKLLUKRG6YB6YIXQ/fx1_lrg-2+-+Tito+Borner.jpg Research - Corrination of a GLP-1 Receptor Agonist for Glycemic Control without Emesis - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.hayes-lab.com/research/gdf15-induces-an-aversive-visceral-malaise-state-that-drives-anorexia-and-weight-loss monthly 0.5 2024-08-06 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1633110064575-ZJNJF1AZLH26R681LURW/F2.large-2+-+Tito+Borner.jpg Research - GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist Induced Nausea and Emesis in Preclinical Models - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.hayes-lab.com/research/gdf15-induces-anorexia-through-nausea-and-emesis monthly 0.5 2024-08-06 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1632944703167-8J00M6XRJW798USSVEPF/1-s2.0-S1550413119306692-fx1_lrg%252B-%252BTito%252BBorner.jpg Research - GDF15 Induces Anorexia through Nausea and Emesis - Make it stand out Borner et al. Cell Metabolism, 2020 https://www.hayes-lab.com/research/fortinstm monthly 0.5 2024-08-06 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1626132735232-C0UQSV0S75JUZ41JPQK0/Screen+Shot+2021-07-12+at+7.30.44+PM.png Research - GLP-1 Receptors action on brainstem GABA neurons - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.hayes-lab.com/research/category/Samantha+Fortin monthly 0.5 https://www.hayes-lab.com/research/category/Rat monthly 0.5 https://www.hayes-lab.com/research/category/Publication monthly 0.5 https://www.hayes-lab.com/research/tag/Incretin monthly 0.5 https://www.hayes-lab.com/research/tag/Caitlin+Baumer-Harrison monthly 0.5 https://www.hayes-lab.com/research/tag/Brainstem monthly 0.5 https://www.hayes-lab.com/research/tag/Caroline+Geisler monthly 0.5 https://www.hayes-lab.com/research/tag/Marcos+Sanchez monthly 0.5 https://www.hayes-lab.com/research/tag/emesis monthly 0.5 https://www.hayes-lab.com/research/tag/GLP monthly 0.5 https://www.hayes-lab.com/research/tag/hindbrain monthly 0.5 https://www.hayes-lab.com/research/tag/chemotherapy monthly 0.5 https://www.hayes-lab.com/research/tag/hypophagia monthly 0.5 https://www.hayes-lab.com/research/tag/aversion monthly 0.5 https://www.hayes-lab.com/research/tag/Musk+Shrew monthly 0.5 https://www.hayes-lab.com/research/tag/Motivation monthly 0.5 https://www.hayes-lab.com/research/tag/ODN monthly 0.5 https://www.hayes-lab.com/research/tag/obesity monthly 0.5 https://www.hayes-lab.com/research/tag/Food+Preference monthly 0.5 https://www.hayes-lab.com/research/tag/Obesity monthly 0.5 https://www.hayes-lab.com/research/tag/Macronutrients monthly 0.5 https://www.hayes-lab.com/research/tag/Tito+Borner monthly 0.5 https://www.hayes-lab.com/research/tag/Cobinamide monthly 0.5 https://www.hayes-lab.com/research/tag/GLP1 monthly 0.5 https://www.hayes-lab.com/research/tag/Insulin monthly 0.5 https://www.hayes-lab.com/research/tag/nausea monthly 0.5 https://www.hayes-lab.com/research/tag/GIP monthly 0.5 https://www.hayes-lab.com/research/tag/Food+Choice monthly 0.5 https://www.hayes-lab.com/research/tag/Microglia monthly 0.5 https://www.hayes-lab.com/research/tag/Chemotherapy monthly 0.5 https://www.hayes-lab.com/research/tag/Leptin monthly 0.5 https://www.hayes-lab.com/research/tag/GFRAL monthly 0.5 https://www.hayes-lab.com/research/tag/GPR160 monthly 0.5 https://www.hayes-lab.com/research/tag/GABA monthly 0.5 https://www.hayes-lab.com/research/tag/Liraglutide monthly 0.5 https://www.hayes-lab.com/research/tag/Antiemetic monthly 0.5 https://www.hayes-lab.com/research/tag/Binge+Eating monthly 0.5 https://www.hayes-lab.com/research/tag/CART monthly 0.5 https://www.hayes-lab.com/research/tag/VTA monthly 0.5 https://www.hayes-lab.com/research/tag/anorexia monthly 0.5 https://www.hayes-lab.com/research/tag/NTS monthly 0.5 https://www.hayes-lab.com/research/tag/vomit monthly 0.5 https://www.hayes-lab.com/research/tag/Mechanism monthly 0.5 https://www.hayes-lab.com/research/tag/area+postrema monthly 0.5 https://www.hayes-lab.com/research/tag/MIC-1 monthly 0.5 https://www.hayes-lab.com/research/tag/Dual+Agonist monthly 0.5 https://www.hayes-lab.com/research/tag/Ghrelin monthly 0.5 https://www.hayes-lab.com/research/tag/Vomiting monthly 0.5 https://www.hayes-lab.com/research/tag/Ventral+Tegmental+Area monthly 0.5 https://www.hayes-lab.com/research/tag/Malaise monthly 0.5 https://www.hayes-lab.com/research/tag/Biased+agonism monthly 0.5 https://www.hayes-lab.com/research/tag/Exendin monthly 0.5 https://www.hayes-lab.com/research/tag/reduced+side+effects monthly 0.5 https://www.hayes-lab.com/research/tag/illness monthly 0.5 https://www.hayes-lab.com/research/tag/TDN monthly 0.5 https://www.hayes-lab.com/research/tag/Impulsivity monthly 0.5 https://www.hayes-lab.com/research/tag/Dopamine monthly 0.5 https://www.hayes-lab.com/research/tag/GDF15 monthly 0.5 https://www.hayes-lab.com/research/tag/Amylin monthly 0.5 https://www.hayes-lab.com/research/tag/Suncus+murinus monthly 0.5 https://www.hayes-lab.com/research/tag/Feeding monthly 0.5 https://www.hayes-lab.com/research/tag/Prefrontal+Cortex monthly 0.5 https://www.hayes-lab.com/research/tag/DVC monthly 0.5 https://www.hayes-lab.com/research/tag/Locus+Coeruleus monthly 0.5 https://www.hayes-lab.com/research/tag/Samantha+Fortin monthly 0.5 https://www.hayes-lab.com/research/tag/B12+brain+permeability monthly 0.5 https://www.hayes-lab.com/research/tag/Diabetes monthly 0.5 https://www.hayes-lab.com/research/tag/Tirzepatide monthly 0.5 https://www.hayes-lab.com/research/tag/Reward monthly 0.5 https://www.hayes-lab.com/research/tag/malaise monthly 0.5 https://www.hayes-lab.com/announcements daily 0.75 2026-08-04 https://www.hayes-lab.com/announcements/welcome-new-postdoc-tina monthly 0.5 2026-08-04 https://www.hayes-lab.com/announcements/welcome-new-research-technician-kayla-nguyen monthly 0.5 2026-07-13 https://www.hayes-lab.com/announcements/welcome-new-research-technician-max-hay monthly 0.5 2026-06-25 https://www.hayes-lab.com/announcements/welcome-new-phd-student-dennis-vu monthly 0.5 2026-06-25 https://www.hayes-lab.com/announcements/new-member monthly 0.5 2026-06-11 https://www.hayes-lab.com/announcements/caroline-geisler-awarded-an-f32-3wnad-4wcwz-yadd5-6net6-lzxfc monthly 0.5 2025-07-24 https://www.hayes-lab.com/announcements/caroline-geisler-awarded-an-f32-3wnad-4wcwz-yadd5-6net6 monthly 0.5 2025-07-24 https://www.hayes-lab.com/announcements/new-member-doctoral-student monthly 0.5 2026-06-11 https://www.hayes-lab.com/announcements/welcome-new-postdoc-genevieve-curtis-pb4cn-3k9j5-jk3ec monthly 0.5 2024-08-06 https://www.hayes-lab.com/announcements/caroline-geisler-awarded-an-f32-3wnad-4wcwz-yadd5 monthly 0.5 2024-08-08 https://www.hayes-lab.com/announcements/welcome-new-postdoc-genevieve-curtis-pb4cn-3k9j5 monthly 0.5 2024-05-30 https://www.hayes-lab.com/announcements/caroline-geisler-awarded-an-f32-3wnad-4wcwz monthly 0.5 2024-08-06 https://www.hayes-lab.com/announcements/caroline-geisler-awarded-an-f32-3wnad monthly 0.5 2024-08-06 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1436e6f0-23a2-4241-923c-9f7f27125346/Fortin.jpeg Announcements - Samantha Fortin Awarded a K01 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.hayes-lab.com/announcements/hayes-postdocs-recognized-at-2022-ssib-conference-g4f7s monthly 0.5 2024-08-06 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/dca06881-a153-410b-9b07-8c356d6e73d9/2023+Endowed+Chair+Ceremony.jpg Announcements - Matt Hayes Recognized as the Albert J. Stunkard Associate Professor in Psychiatry - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.hayes-lab.com/announcements/hayes-postdocs-recognized-at-2022-ssib-conference monthly 0.5 2024-08-06 https://www.hayes-lab.com/announcements/category/New+Member monthly 0.5 https://www.hayes-lab.com/announcements/category/Grant monthly 0.5 https://www.hayes-lab.com/announcements/category/Ceremony+Award monthly 0.5 https://www.hayes-lab.com/announcements/category/Rat monthly 0.5 https://www.hayes-lab.com/announcements/category/Publication monthly 0.5 https://www.hayes-lab.com/announcements/category/Conference+Award monthly 0.5 https://www.hayes-lab.com/announcements/category/Presentation monthly 0.5 https://www.hayes-lab.com/announcements/category/Conference monthly 0.5 https://www.hayes-lab.com/announcements/category/Postdoctoral+Researcher monthly 0.5 https://www.hayes-lab.com/announcements/category/Samantha+Fortin monthly 0.5 https://www.hayes-lab.com/announcements/category/Grant+Award monthly 0.5 https://www.hayes-lab.com/announcements/category/Award monthly 0.5 https://www.hayes-lab.com/announcements/category/PhD+Graduate+Student monthly 0.5 https://www.hayes-lab.com/home daily 1.0 2025-08-28 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1632847889710-P8MCCCN5IR4GYW9O6AA9/unsplash-image-98MbUldcDJY.jpg Home https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1632847931460-J7KZ0UPEE4HIPRZTDUCZ/unsplash-image-IHfOpAzzjHM.jpg Home https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1632848041487-F4PJR3L4EWF9AP0VG2SK/unsplash-image-fHGdXjY6JWI.jpg Home https://www.hayes-lab.com/team daily 0.75 2026-07-13 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1626117697473-1YEFDWGH25KQZC2XG2YN/Image%2Bfrom%2BiOS.jpg Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1632784202780-95H2YB0XE0FRVMR4T7MU/unsplash-image-8XDfQmFImtQ.jpg Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/64f1440e-4fc5-4664-b88b-31fb4136a5ce/Image+from+iOS.jpg Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/f455e70f-12de-4ad8-908c-36a295051b93/JWH_3873.jpeg Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1736faf3-8419-47c4-a0f5-b2d1590f5a45/Image_for_lab.jpg Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/b4dd2385-9a7e-4bb3-b877-772af474e6b4/processed-5719079C-AE43-4FCA-9CF2-90ABEF9E53FC.jpeg Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/b5f5ae60-e2fa-4e48-9963-ebece5e16409/DSCF2091.jpg Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/c1da18f6-c2fb-445c-b9f4-b64bb59caeee/IMG_9364.jpg Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/40ef914f-45f8-4ba5-b964-8247fd011e16/IMG_8445.jpg Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/3b30a00e-d3ff-4759-a9c7-9f8d949d4440/Image+from+iOS+%282%29.jpg Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/b194f7e5-2731-4289-ac4b-e04544a0bb26/IMG_1756.jpg Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/643ed54a-1fa9-4a8a-ba93-4f8cac997be5/Image+from+iOS+%283%29.jpg Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/908631f2-29f6-453b-b750-6759e73caa36/IMG_3687.jpg Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/c05104bd-d6cf-4bbf-97b3-6d2ada3b2b7e/IMG_1247.JPEG Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/d9b938ea-137f-471e-8842-4dc67c63ab2f/IMG_0166.jpg Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/a073f6b9-f7ce-4259-a66e-22d0cd52f16c/d45020657dd329167a558b4f45d1c2eb.jpg Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/4e8bdf79-26d0-4b19-b197-f9da5d1a5600/Image+from+iOS+%281%29.jpg Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1783969121939-2FA43597X284SJLOMF0M/IMG_6808.jpg Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/e6020f9a-d51a-479f-9d52-bfb410dd935a/IMG_3952.jpg Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1781217540485-II53SKGTO1ZVPBO20T1J/image002.png Team https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1625685858557-USS26RLVELFMGJ5EFLYJ/Matt+Hayes+Headshot Team - Matthew R. Hayes, PhD Principal Investigator hayesmr@pennmedicine.upenn.edu https://www.hayes-lab.com/contact-1 daily 0.75 2025-09-09 https://www.hayes-lab.com/cgeisler daily 0.75 2023-02-28 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/42736058-d0e1-4445-9901-3821bfae4b9f/VTA+amylin+GABA.png cgeisler https://www.hayes-lab.com/goodtimes daily 0.75 2022-07-29 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/b715737f-d3ee-43e5-90d6-6839fbefdd25/IMG_0464.png Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/57215c94-3a11-4de0-a5ed-c6284970ec5f/IMG_0465.png Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/a7ff7c04-fea0-4622-ba44-eb6c9536ec06/IMG_0466.png Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/ec1a204d-0695-4740-a0d2-8f2540e0bf97/IMG_4445%5B58%5D.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/15f79beb-6d4c-4a40-a063-a1c09d41ad91/image000000%285%29.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/627b5b72-e274-4662-8e38-9a1a355930c5/IMG_0217.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/91d680d6-74d5-48ce-b990-dc341397f8e8/2D5680B1-E2F1-46F0-A820-9B6DD9B6CE1C.jpeg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/cc4adcc7-c9c0-400e-be57-1f19b188e867/IMG_8425.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/496fa243-20b5-486d-ad9e-d4f0d90abb02/IMG_0389.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/777cc1b8-caf5-4f38-b56c-da8d671a4aaf/IMG_3747.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/d70ca8c6-cd44-4199-aa24-7c19d2faf696/IMG_3579.JPG Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/73454f49-7d1a-4be1-a85a-b326e1130c23/0759_LaurenLouis_090421.JPG Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/5caeeb7a-369d-4beb-b44d-15905b83c70d/IMG_3745.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1659208672154-1WYZ6D8H1XB7NMSG7ABA/20220716_220946.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/607ca534-8455-46b3-92b4-4be434cf383f/tito_lab.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/a11bcb5e-ec10-4036-8865-3fa6a7358e76/IMG_4290.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/21f4d633-580a-4b81-8c60-1d8599e542eb/IMG_3117.JPG Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/907aef8c-0539-42ec-ae00-9fd40e9cbdbd/IMG_0387.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/7fdeca87-0c83-43f8-bf34-d3a31bd54f4f/IMG_2994.JPG Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/ee5593e3-a1a1-47a6-a1ec-8f9e008311f8/0762_LaurenLouis_090421.JPG Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/954dc76d-fa28-4728-a6e8-0f274d1499bf/IMG_0383.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/2f002fad-c037-4789-a387-670dd911a72e/IMG_1335.JPG Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/da4f1047-d68a-4272-96b0-ec3dde4c6f51/20220321_144534.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/6225b2d1-b9f2-4691-b8a7-6c19ec4f3a06/IMG_5190.JPG Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/87bfe554-5df7-45e2-9011-c96f15401fca/IMG_0214.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1625758754477-CMD5PHB23WWQVT7G89YK/IMG_3757.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/c6f9c7b5-f240-4ed3-875b-722949986943/20210527_110626.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/39d7fc32-687d-4196-9b61-b4ae326490f3/Image+from+iOS+%281%29.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/373e9590-b23d-484f-94b1-548851db7946/IMG_0401.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/d3a953a8-e8ed-4c7d-8244-45100cfcf4e0/20220716_220937.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/3100c0f2-de56-4def-b475-235a497e6d03/sam_tito_xmas.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/690f58d1-20c9-4a1a-b13d-1d0b52e07348/IMG_3671.png Good Times Lab Happy Hour 2021 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/6556e07e-f69c-401f-8c76-31b2f06a8823/CA25C43F-4ABC-4D5D-8390-B2C31E1304FD.JPG Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/5fa4321e-8021-4313-ab5c-f64a5d9df7d5/IMG_3703.png Good Times Lab Meeting 2021 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/de5ad494-47a1-40e5-a797-4cbc02aa9208/62a69a42-.JPG Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/154f1a9e-9b34-4ed7-869b-a208a690cda8/IMG_0756.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/a5992f1b-64d8-4dc6-8193-4bc8f7ea5ddb/IMG_1429.JPG Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/14b0629f-fd97-4e31-8cf5-82b4573c3f7c/Resized_20220617_104206.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/80718ade-8b2b-4c6b-9d1f-6236e63fb8a6/IMG_5355.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/65cc6c9e-ca97-4db3-ab5e-057714317c9a/20220321_144602.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/e6fdc2ff-8bee-41f0-a818-6fc80399fc48/IMG_0025.jpg Good Times SSIB 2019 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/94096866-581c-411d-97f5-bab9bb188208/IMG_1426.JPG Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/d8346fc3-4747-4102-8dc3-58d6a12ecd3c/IMG_5739.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/7bb10e54-66b8-40a8-89d5-0543a910c515/IMG_0335.JPG Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/291cd4a0-70ea-489a-9398-b020fc4c4b80/IMG_0069.JPG Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/d111c74c-fced-4a4f-aa74-d2103ed9f3ac/IMG_2814.jpeg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/6602558e-2d1e-44ac-a9c1-f7c099fa80f4/IMG_2623.jpeg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/aa3f0272-a9ba-4421-85cd-cf765fe1481a/IMG_0068.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/a1c3ef79-a235-4a70-8b37-dff9a2c77ddb/IMG_0016.JPG Good Times SSIB 2019 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/23f82df6-ceea-4fe2-8988-d46ec10c9435/20220321_115902.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/094c1743-9e51-49f0-bc56-6e1542ea5fbf/IMG_33062.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/742b7bfc-ec2a-4dd9-a30a-db877bf6dc2a/IMG_1106.JPG Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/a65a5209-306f-4060-ac64-54de80585a13/IMG_0134.jpg Good Times SSIB 2019 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/aa52b70d-e665-4277-a572-352d1d2d0fa9/IMG_1431.JPG Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/4efad963-d652-46b0-b2d8-5496f8bf2a54/IMG_0755.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/0e2ab2b8-6c14-40e3-bdb4-af7efeb53b12/IMG_4316.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1638304237484-90LXZDMI88QM99TK9IZ1/IMG_0991.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/ae688313-c1a2-4c7a-9a0b-e0bb73aef52e/BC2B453D-F812-4D07-9C88-683543934B56.jpeg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/82452e94-020a-4c9c-8093-a09f3d4d33eb/6D12EDC7-8529-4D03-A35C-C30010971B2A.jpeg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/5cc92795-9e5b-4a63-a547-523ee6d2a279/IMG_2436.jpeg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/17e3331e-5f43-4a3b-afa3-9c512c8d8d29/20220322_144227.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1a576465-ee93-4e87-ba0f-6c253be6e8d1/IMG_0369.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/874fc132-0750-4d68-9c22-965499981c27/IMG_2633.JPG Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/f2b8e2ed-91c3-4b5e-b4c8-44e48da92d1f/FBA189A1-B883-4278-8517-8FBD332FD59D.JPG Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/64abc49f-7479-4298-8fc0-2c66873a1e49/9712.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1638304330043-928Y6XCHC57JMDCPQI1Y/IMG_2957.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/35efe564-837e-4526-8bc4-58d15d888286/IMG_1646.jpeg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/40fa4801-cb79-4d85-84ca-2821adece24e/IMG_1210.JPG Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/38196dcb-7d82-4c2f-a494-4ad53525d494/IMG_5750.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/cac9e365-f03b-4d5c-9999-6bf699fe60ea/20220716_212006.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/9c6df1da-b476-441a-b177-bf5c8ac183e0/IMG_0393.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/f2616d50-26ec-46d1-a1d2-ca7e4de840d5/20230517_114630.jpg Good Times https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1f15c182-a634-499b-b00c-57f500e448f4/IMG_3898.jpg Good Times https://www.hayes-lab.com/technicians daily 0.75 2026-07-13 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/84e76b2e-6ed3-42b4-a486-fe371ac4b688/Image+from+iOS.jpg techs https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/4e8bdf79-26d0-4b19-b197-f9da5d1a5600/Image+from+iOS+%281%29.jpg techs - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/dce99d70-ffd7-458e-afe2-ce2a8f3b930a/IMG_3687.jpg techs - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1783969121939-2FA43597X284SJLOMF0M/IMG_6808.jpg techs - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1711625e-7ae0-4e2d-be27-28254718f4ee/DSCF2091.jpg techs - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.hayes-lab.com/sappleby daily 0.75 2026-06-10 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1632786219175-B0W5RGU64AKKITB6EAB8/IMG_0847%2B-%2BSarah%2BApplebey.jpg sappleby - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.hayes-lab.com/mhayes daily 0.75 2023-07-24 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1625685858557-USS26RLVELFMGJ5EFLYJ/Matt%2BHayes%2BHeadshot mhayes https://www.hayes-lab.com/marcos daily 0.75 2026-06-10 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1626117697473-1YEFDWGH25KQZC2XG2YN/Image%2Bfrom%2BiOS.jpg marcos - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.hayes-lab.com/cbaumerharrison daily 0.75 2025-02-07 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1698168845887-SJM3XSDA0Y6GFKESI6SV/JWH_3873.jpeg cbaumerharrison - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.hayes-lab.com/sfortin daily 0.75 2025-02-07 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1436e6f0-23a2-4241-923c-9f7f27125346/Fortin.jpeg sfortin - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.hayes-lab.com/maggie daily 0.75 2025-02-07 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/b4dd2385-9a7e-4bb3-b877-772af474e6b4/processed-5719079C-AE43-4FCA-9CF2-90ABEF9E53FC.jpeg Maggie - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.hayes-lab.com/ksubramanian daily 0.75 2025-02-07 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1717082198583-Z6L1UCSAK1XBNLQZHGR1/Image_for_lab.jpg ksubramanian - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.hayes-lab.com/dennis daily 0.75 2026-06-10 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/9caf6943-ab60-49be-af15-87d8827bf8f7/IMG_9364.jpg Dennis - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.hayes-lab.com/tina daily 0.75 2026-08-03 https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1781217540485-II53SKGTO1ZVPBO20T1J/image002.png Tina - Make it stand out Whatever it is, the way you tell your story online can make all the difference.